In large-scale clinical trials of NXY-059, this neuroprotective agent demonstrated no notable efficacy in humans [30]
A., Smith, F
The combination lets a lower dose of each achieve a stronger effect, which can also mean fewer side effects than pushing a single peptide hard
Cardiovascular and Renal Considerations Several GLP-1 receptor agonists (specifically liraglutide, semaglutide, and dulaglutide) have demonstrated cardiovascular benefits in clinical trials
That being said, the high doses of the nootropic measured at 0.5 mg/kg/day for intraperitoneal delivery and 2.0 mg/kg/day for oral delivery, and resulted in a performance that was indistinguishable from the control group and significantly better than the animals treated with scopolamine alone [2]
Mitochondrial GR is essential for: Protecting the electron transport chain components from oxidative damage Maintaining mitochondrial DNA integrity against oxidative lesions Supporting ATP production by preserving mitochondrial membrane potential Preventing mitochondrial-initiated apoptosis triggered by excessive oxidative stress Facilitating mitochondrial glutathione transport and utilization The mitochondrial glutathione system is particularly critical in neurons and other cells with high energy demands, where mitochondrial dysfunction can have catastrophic consequences